These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2934223)

  • 41. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
    Leis D; Botterman P; Ermler R; Maurer U
    Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK; Doyle LV; Bradley EC
    J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoregulatory T cells in measles. The relationship between reduced lymphocyte proliferative response to PHA and increased proportion of circulating suppressor-cytotoxic T cells.
    Bertotto A; Rambotti A; Gentilini F; Stefanelli M; Zucchetti P; Vaccaro R
    Microbiologica; 1984 Jan; 7(1):21-7. PubMed ID: 6233473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral contraceptives. Who, which, when, and why?
    Marut EL
    Postgrad Med; 1987 Sep; 82(4):66-70. PubMed ID: 3628138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
    Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
    J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The metabolic impact of oral contraceptives.
    Krauss RM; Burkman RT
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diurnal variation of lymphocyte subsets identified by monoclonal antibodies.
    Bertouch JV; Roberts-Thomson PJ; Bradley J
    Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1171-2. PubMed ID: 6220755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptive use and the risk of chlamydial and gonococcal infections.
    Louv WC; Austin H; Perlman J; Alexander WJ
    Am J Obstet Gynecol; 1989 Feb; 160(2):396-402. PubMed ID: 2916625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels.
    Saleh WA; Burkman RT; Zacur HA; Kimball AW; Kwiterovich P; Bell WK
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1740-5; discussion 1745-7. PubMed ID: 8317516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron stores in users of oral contraceptive agents.
    Frassinelli-Gunderson EP; Margen S; Brown JR
    Am J Clin Nutr; 1985 Apr; 41(4):703-12. PubMed ID: 3984924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of various contraceptive hormonal therapies in women with normal and diabetic oral glucose tolerance test.
    Aznar R; Lara R; Zarco D; González L
    Contraception; 1976 Mar; 13(3):299-311. PubMed ID: 55331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.
    Pedersen C; Kolby P; Sindrup JH; Arendrup M; Wulf HC; Gaub J; Gerstoft J; Lindhardt BO
    Dan Med Bull; 1986 Oct; 33(5):270-2. PubMed ID: 2946558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depletion of T-lymphocyte subsets using monoclonal antibody and complement: effect on T-colony formation.
    McCluskey DR; Kelly GJ; Morris TC; Bridges JM
    Int J Cell Cloning; 1984 Sep; 2(5):296-303. PubMed ID: 6238108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of oral contraceptives on plasma androgenic steroids and their precursors.
    Fern M; Rose DP; Fern EB
    Obstet Gynecol; 1978 May; 51(5):541-4. PubMed ID: 148599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease.
    Gaspard UJ; Lefebvre PJ
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):334-43. PubMed ID: 2196805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative study of Norinyl 1/35 versus Lo-Ovral in Ile-Ife Nigeria.
    Ayangade O; Akinyemi A
    Int J Gynaecol Obstet; 1989 Oct; 30(2):165-70. PubMed ID: 2572488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-dimensional flow cytometric analysis of T cell subsets maintained in IL-2 medium after autologous mixed leukocyte reaction activation.
    Goto M; Miyamoto T; Nishioka K
    Microbiol Immunol; 1988; 32(4):375-85. PubMed ID: 2969076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of oral contraceptive agents on the basal metabolic rate of young women.
    Diffey B; Piers LS; Soares MJ; O'Dea K
    Br J Nutr; 1997 Jun; 77(6):853-62. PubMed ID: 9227183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.